Nov 10, 2022 by James HalleyWhy Shares of Teladoc Rose 15.77% on ThursdayMarket forces, and the lingering benefit of improved third-quarter numbers, drove the stock up.
Nov 10, 2022 by James HalleyWhy TG Therapeutics' Shares Rose 63.37% on ThursdayThe company had a nugget of good news in its third-quarter report.
Nov 10, 2022 by James HalleyWhy EQRx Shares Dropped 28.62% on ThursdayThe company suspended trials for one of its lead therapies.
Nov 10, 2022 by James Halley3 Top Healthcare Stocks Defying the Bear MarketThese healthcare companies haven't been slowed by macroeconomic conditions.
Nov 9, 2022 by James HalleyWhy Shares of Bioventus Fell 14% on WednesdayThe company's reduced guidance concerned investors.
Nov 9, 2022 by James HalleyWhy Shares of Health Catalyst Popped 23.34% on WednesdayThe company continued its upward trend in revenue growth.
Nov 9, 2022 by James HalleyWhy Shares of Eastman Kodak Slumped 23.64% on WednesdayInvestors saw cause for concern in the company's third-quarter earnings.
Nov 8, 2022 by James HalleyWhy Shares of Gilead Sciences Rose 27.20% in OctoberThe company's growing oncology portfolio is driving increased revenues.
Nov 8, 2022 by James Halley3 No-Brainer Stocks to Buy in a DownturnThese companies thrive when others falter.
Nov 8, 2022 by James HalleyThese 3 Dividend ETFs Are a Retiree's Best FriendThis trio of exchange-traded funds has trounced the S&P 500 this year.
Nov 7, 2022 by James HalleyWhy Shares of Doximity Dropped 12.4% in OctoberInvestors are expecting lower Doximity revenue from advertising.
Nov 7, 2022 by James HalleyWhy Verve Therapeutics' Stock Dropped 26.33% on MondayA trial for the company's lead therapy was put on hold.
Nov 7, 2022 by James HalleyWhy Shares of CRISPR Therapeutics Dropped 19.9% in OctoberSeveral factors weighed on the gene-editing biotech stocks last month.
Nov 7, 2022 by James Halley2 Pet Medicine Stocks That Make Great Long-Term InvestmentsTwo of the biggest names in animal care continue to grow.
Nov 5, 2022 by James Halley2 Under-the-Radar Medtech Stocks to Buy NowDon't count out these discounted medical technology stocks.
Nov 5, 2022 by James HalleyIs Johnson & Johnson's Purchase of Abiomed Good for Investors?The $16.6 billion acquisition shakes up MedTech.
Nov 4, 2022 by James HalleyWhy Shares of Catalent Fell 36% This WeekLowered guidance and earnings concerned investors.
Nov 4, 2022 by James HalleyWhy Shares of Omnicell Dropped 33.6% This WeekThe healthcare medication management company released lowered guidance.
Nov 3, 2022 by James HalleyWhy Shares of Myriad Genetics Dropped 24% This WeekThe genetic-testing company announced an acquisition and lowered its guidance.
Nov 3, 2022 by James HalleyIs This Chinese Pharmaceutical Stock Worth the Risk?BeiGene's shares are down this year, but it has two potential blockbusters.
